NYSE:RMDMedical Equipment
ResMed (RMD) Could Be 14% Undervalued On Its Sleep Health Growth Story
ResMed stock performance and business snapshot
ResMed (RMD) has drawn investor attention after recent share price gains over the past week and month, set against weaker returns over the past year and year to date.
The stock last closed at US$214.29, giving the company a market value of about US$30.1b. Reported annual revenue stands at US$5.54b with net income of US$1.52b, supported by two main segments in sleep and breathing health, and residential care software.
See our latest analysis for...